OTCMKTS:ADOCY Adocia (ADOCY) Stock Price, News & Analysis $11.80 0.00 (0.00%) As of 07/1/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Adocia Stock (OTCMKTS:ADOCY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Adocia alerts:Sign Up Key Stats Today's Range$11.80▼$11.8050-Day Range$11.80▼$11.8052-Week Range$9.80▼$11.80VolumeN/AAverage VolumeN/AMarket Capitalization$215.70 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France. Read More Receive ADOCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adocia and its competitors with MarketBeat's FREE daily newsletter. Email Address ADOCY Stock News HeadlinesAdocia raises €9.7 million in private placement, extending cash runway to Q2 2026February 26, 2025 | msn.comADOCIA Announces the Release of Its Universal Registration Document for the Year 2023April 29, 2024 | finance.yahoo.comAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.July 2 at 2:00 AM | Paradigm Press (Ad)ADOCIA Announces Full Year 2023 Financial Results and Provides a Corporate and Financial UpdateApril 26, 2024 | finance.yahoo.comADOCIA Announces Its Participation at Key EventsMarch 6, 2024 | finance.yahoo.comADOCIA Reports Fourth Quarter 2023 Financial Results and Provides a Business UpdateFebruary 27, 2024 | finance.yahoo.comADOCIA Announces its Financial Calendar for 2024January 25, 2024 | finance.yahoo.comADOCIA Revealed Promising Preclinical Data on AdoShell® Islets for Cell Therapy of DiabetesNovember 9, 2023 | finance.yahoo.comSee More Headlines ADOCY Stock Analysis - Frequently Asked Questions How have ADOCY shares performed this year? Adocia's stock was trading at $11.80 on January 1st, 2025. Since then, ADOCY shares have increased by 0.0% and is now trading at $11.80. View the best growth stocks for 2025 here. How do I buy shares of Adocia? Shares of ADOCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today7/02/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - BIOMED/GENE Sub-IndustryN/A Current SymbolOTCMKTS:ADOCY CIKN/A Webwww.adocia.com Phone33-04-72-61-06-10Fax33-04-72-36-39-67Employees78Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.08 Quick Ratio1.07 Sales & Book Value Annual Sales$13.12 million Price / Sales16.44 Cash FlowN/A Price / Cash FlowN/A Book Value($0.21) per share Price / Book-56.19Miscellaneous Outstanding Shares18,280,000Free FloatN/AMarket Cap$215.70 million OptionableNot Optionable Beta-0.12 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:ADOCY) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Pentagon just made a National Security move...This "awesome resource" could power America for 30,000 years... We sent one of our smartest researchers.......Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adocia Please log in to your account or sign up in order to add this asset to your watchlist. Share Adocia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.